Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECBLOCK pectoral nerve block for pain after breast cancer surgery
2013-002764-12Phase 4Completed
- Sponsor
- CHU de Limoges
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain and breast cancer, sponsored by CHU de Limoges. Primary endpoint: Pain score at rest in the recovery room. Started Sep 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative painbreast cancer
Beyond the preview
Go deeper on 2013-002764-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002764-12.